IMPACT OF SELF-EFFICACY THEORY ON IMPROVING ADHERENCE OF OLDER ADULTS PATIENTS WITH GLAUCOMA’S MEDICATION
DOI:
https://doi.org/10.47604/jhmn.1160Abstract views: 369
PDF downloads: 347
Keywords:
Self-Efficacy, Medication Adherence, Older Adults, GlaucomaAbstract
Purpose: This study was aimed to measure the impact of self-efficacy theory to improve medication adherence among older adults’ patients with glaucoma.
Methodology: A quasi-experimental design was used to investigate the study hypotheses.
Study Sample: A total of 284 older adults with glaucoma were screened to select non-adherent patients with medication. The recruited study sample was (152) who are non-adherent with glaucoma medication divided equally into (76 study group) and (76 control group). Setting: the study was conducted at the outpatient clinics of Ophthalmology at University Hospital, Shebin El-Kom, Egypt. Tools: three tools were used for the purpose of data collection (I) Bio-socio-demographic characteristics questionnaire; (II) Medication Adherence Rating Scale (III) Glaucoma Medication Self-Efficacy Scale.
Findings: The findings revealed that the mean age of the studied sample was 74.86+4.63 (non-adherent to medication). Patients age and presence of more than three multiple chronic illnesses with poly-medications are the highest risk factors of adherence to medications (OR = 10.9; 95% CI 6.8 -16.32, P = 0.000); (OR = 12.6; 95% CI 8.2 -18.4, P = 0.000) and (OR = 13.2; 95% CI 7.4 -19.8, P = 0.000) respectively. Participants who received the intervention program showed a significant improvement in their self-efficacy in overcoming medication adherence barriers compared to the control group. An improvement of the self-efficacy in their ability in carrying out glaucoma medication correctly compared to the control group was shown by highly statistically significant differences between total mean scores at (t =3.426, P =.001; t =17.174, P=.000; t =18.141, P=.000) respectively. The intervention program of glaucoma medication management had a positive impact on the patients’ outcomes compared to the control group. There is a statistically significant difference between patients’ feelings and thoughts pre and post-intervention was detected.
Unique contribution to theory, practice and policy: The findings confirm the effectiveness of an intervention/educational program based on self-efficacy theory in terms of improving glaucoma medication adherence among older adults. Glaucoma’s medication principles should be discussed at regular intervals based on patients' needs and the barriers they are facing.
Downloads
Download data is not yet available.
References
1. • Flaxman SR, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. The Lancet Global Health, 2017 Dec; 5(12):e1221-e1234. DOI: 10.1016/S2214-109X (17)30393-5.
•
2. Tham Y, Li X, Wong TY, Quigley HA, Aung T, Cheng C. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology, 2015 July; Volume 122, Issue 7, Pages e40-e41.
3. World Health Organization. Situation Analysis of VISION 2020 in the WHO South-East Asia Region. 2012.
4. International Agency for the Prevention of Blindness (IAPB): Annual Report 2019.
https://www.iapb.org/wp-content/uploads/2019_IAPB_Annual_Report.pdf.
5. Abu Hussein NB, Eissa IM, Abdel-Kader AA. Analysis of Factors Affecting Patients’ Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model. J Ophthalmol., 2015. https://www.ncbi.nlm.nih.gov/pubmed/26167292.
6. Amin AM, Kamel AIM, El-Ashkar MGA. Corneal Topographic changes after sub scleral trabeculectomy. AIMJ 2020 February. doi:10.21608.
7. Khalaf FR, Qayed M, Fahmy HD, Wasfi EI, Mohamed AG. Employees Knowledge about
Glaucoma at Assiut University Employees. Assiut Scientific Nursing Journal. 2015 June; 3(5):11-17.
8. Smaje A, Clark MW, Raj R, Orlu M, Davis D, Rawle M. Factors associated with medication adherence in older patients: A systematic review. Aging Med (Milton). 2018 Dec; 1(3): 254–266.
9. Facts About Glaucoma". National Eye Institute. Archived from the original on 2016 March 28.
10. Eldaly MA, Salama MM, Abu Eleinen KG, Ghalwash D, Youssef M, El-Shiaty AF. Blindness and Visual Impairment among Egyptian Glaucoma Patients. Journal of Ophthalmology, 2014; Article ID 437548.
11. Vos T. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study. Lancet 2016; 388: 1545–602.
12. Zhong H, et al. The Prevalence of Glaucoma in Adult Rural Chinese Populations of the Bai
Nationality in Dali: The Yunnan Minority Eye Study. Investigative Ophthalmology & Visual
Science, 2012 May; Vol.53, 3221-3225. doi: https://doi.org/10.1167/iovs.11-9306.
13. National Eye Institute. Glaucoma: The “silent thief begins to tell its secrets”. 2015 January. Archived from the original on 23 July,2014.
14. Mantravadi AV, Vadhar N. Glaucoma - Primary Care: Clinics in Office Practice, 2015 Sept; Volume 41, Issue 3,P437-449 DOI: https://doi.org/10.1016/j.pop.
15. Vin A, Schneider S, Muir KW, Rosdahl JA. Health coaching for glaucoma care: a pilot study
using mixed methods. Clinical ophthalmology (Auckland, N.Z.). 2015 Oct 22; 9:1931-43.
16. Sleath B, et al. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology, 2015 Apr 1; 122(4):748-54.
17. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163–96.
18. Mahmoodi H, Jalalizad NF, Shaghaghi A, Shooshtari S, Jafarabadi MA, Allahverdipour H. Gender Based Cognitive Determinants Of Medication Adherence In Older Adults With Chronic Conditions. Patient Preference and Adherence, 2019 October 15; Volume:13 Pages 1733—1744. DOI https://doi.org/10.2147/PPA.S219193.
19. Lee S, Jiang L, Dowdy D, Hong YA, Ory MG. Attitudes, Beliefs, and Cost-Related Medication Nonadherence Among Adults Aged 65 or Older with Chronic Diseases. Prev Chronic Dis 2018; 15:180190. DOI: http://dx.doi.org/10.5888/pcd15.180190external icon.
20. Patton DE, Cadogan CA, Ryan C, Francis JJ, Gormley GJ, Passmore P, Kerse N, Hughes CM. Improving adherence to multiple medications in older people in primary care: Selecting intervention components to address patient-reported barriers and facilitators. Health Expect. 2018 Feb; 21(1):138-148. doi: 10.1111/hex.12595.
21. Patton DE, Hughes CM, Cadogan CA, Ryan CA. Theory-Based Interventions to Improve Medication Adherence in Older Adults Prescribed Polypharmacy: A Systematic Review. Drugs and Aging, 2017; 34:97–113 DOI 10.1007/s40266-016-0426-6.
22. Sleath B, et al., Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations. Eye (2010) 24, 624–631.
23. Kashiwagi K, Furuya T. Persistence with topical glaucoma therapy among newly diagnosed Japanese patients. Japanese Journal of Ophthalmology, 2014: volume 58, pages 68–74.
24. Campbell J, Schwartz G, LaBounty B, Kowalski J, Patel V. Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions. 2014 May; Volume 4:8 Pages 927-935.
25. McVeigh K, Vakros G. The eye drop chart: A pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clinical ophthalmology, 2015 May. DOI: 10.2147/OPTH.S82909.
26. Verloo H, Chiolero A, Kiszio B, Kampel T, Santschi V. Nurse interventions to improve medication adherence among discharged older adults: a systematic review. Age & Ageing, 2017 Sept; 46(5):747-754. doi: 10.1093/ageing/afx076.
27. Iuga AO and McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014 Feb 20; 7:35-44. doi: 10.2147/RMHP.S19801.
28. Al-Lawati S. Report on Patient Non-adherence in Ireland. Dublin: Pfizer Healthcare Ireland, Irish Pharmacy Union, Irish patients’ Association; 2014 March; Pp 52.
29. Vrijens B, et al., A new taxonomy for describing and defining adherence to medications. Br J
Clin Pharmacol. 2012 May; 73(5):691-705. doi: 10.1111/j.1365-2125.2012.04167
30. Lopez-Garrido G. Self-efficacy. Simply Psychology, Aug 09, 2020, https://www .simply psychology.org/self-efficacy.html
31. Conner MT. Cognitive Determinants of Health Behavior. Handbook of Behavioral Medicine.
2010 August; pp 19-30. DOI: 10.1007/978-0-387-09488-5_2
32. Bandura A. Social cognitive theory: an agentic perspective. Annu Rev Psychol., 2001; 52:1-26.
doi: 10.1146/annurev.psych.52.1.1.
33. Redmond BF. Self- efficacy Theory: Do I Think that I can succeed in my work? Work attitudes & motivations. (2010), The Pennsylvania state University; World Campus
34. Bandura A. Self-efficacy: toward a unifying theory of behavioral change Psychol Rev. 1977
Mar; 84(2): 191-215. doi: 10.1037//0033-295x.84.2.191.
35. Schunk DH. "Goal Setting and Self-Efficacy During Self-Regulated Learning" . Educational Psychologist, 2010 Jun 08; Pages 71-86.
36. Conner M, & Norman P. Predicting health behavior (2nd ed.). Buckingham, England: Open University Press. 2005.
37. Porter LW, Bigley GA, Steers RM. Motivation and Work Behavior. McGraw-Hill Irwin, Digital format Book, 2011 April; (7th ed.), p. 131–132.
38. Bandura A. Social Learning Theory, Alexandria, VA: Prentice Hall, 1977, pp. 247, ISBN 978-0- 13-816744-8.
39. Atkins L, et al., A guide to using the theoretical domains framework of behavior change to investigate implementation problems. Implement Sci.,2017 Jun 21;12(1):77. DOI: 10.1186/s
13012-017-0605-9.
40. Michie S, et al., The behavior changes technique taxonomy (v1) of 93 hierarchically clustered techniques: Building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013; 46:81‐95.
41. Hughes CM; Cadogan CA; Patton D; Ryan CA. Pharmaceutical strategies towards optimizing polypharmacy in older people. Int J Pharm. 2016; Volume 512, Issue 2:360‐365.
42. Patton DE, Ryan C, Hughes CM. Development of a complex community pharmacy intervention package using theory-based behaviour change techniques to improve older adult’s medication adherence, BMC Health Services Research, 2020. 10.1186/s12913-020-05282-7.
43. Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current Situation of Medication Adherence in Hypertension. Front. Pharmacol.,2017, March. https://doi.org/10.3389/fphar.2017.00100.
44. Kardas P, Lewek P, Matyjaszczyk M . Determinants of patient adherence: a review of
systematic reviews. Front Pharmacol. 2013 Jul 25; 4: 91. Doi:10. 3389/ fphar.2013.00091.
45. Navarra AMD, Gwadz MV, Bakken S, Whittemore R, Cleland CM, Melkus GD. Adherence
Connection for Counseling, Education, and Support: Research Protocol for a Proof-of-
Concept Study. JMIR Res Protoc. 2019 Mar; 8(3): e12543. doi: 10.2196/12543.
46. Lubloy A. Factors affecting the uptake of new medicines: a systematic literature review.
BMC Health Services Research. 2014; 14:469
47. Unni EJ , Olson JL , Farris KB. Revision and validation of Medication Adherence Reasons
Scale (MAR-Scale). Journal Current Medical Research and Opinion . 2014, Volume 30, Issue 2.
48. Herndon LW, Brunner TM, Rollins JN. The Glaucoma Research Foundation Patient
Survey: patient understanding of glaucoma and its treatment. Am J Ophthalmol., 2006; 141:
22–28.
49. Ma HJ, Yen M, Chen CH, Liou D (2015). Determinants of the medication adherence behavior
among elderly patients with coronary heart diseases. Journal of Nursing Education and
Practice, 2015, Vol. 5, No.7
50. Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, Taddei G C, Casati M, Franchi C, Djade C D, Nobili A. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014 Apr;31(4):283- 9. doi: 10.1007/ s40266-014-0163-7.
51. Pagès-Puigdemont N, Tuneu L, Masip M, Valls P, Puig T, Mangues MA. Determinants of medication adherence among chronic patients from an urban area: a cross-sectional study.
European Journal of Public Health, Jun 2019; Volume 29, Issue 3, Pages 419–424.
52. Kharameh ZT, Khoshravesh S, Nouri R, Abdolmalaki M, Bakhshi M. Determinants of
Medication Adherence Among Iranian Elderly Patients with Chronic Diseases. Jundishapur
Journal of Chronic Disease Care in Press (In Press). 2018. DOI: 10.5812/jjcdc.68310.
53. Sirey JA, Weinberger MI, Greenfield A, Bruce ML. Medication beliefs and self-reported
adherence among community-dwelling older adults. Clinical Therapeutics, 2013 26 Jan,
35(2):153-160. DOI: 10.1016/j.clinthera.2013.01.001.
54. Al-Mansouri FA, Kanaan A, Gamra H, Khandekar R, Hashim SP, Al Qahtani O, Ahmed MF. Prevalence and Determinants of Glaucoma in Citizens of Qatar Aged 40 Years or Older:
A Community-Based SurveyMiddle East Afr J Ophthalmol. 2011 Apr-Jun; 18(2): 141-149.doi:10.4103/0974-9233.80703.
55. Zucker I & Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug
reactions in women. Biology of Sex Differences volume 11, Article number: 32 (2020).
56. Marcos-Marcos J; Gasch-Gallén A; Mateos JT; Álvarez-Dardet C. Advancing gender
equ(al)ity, lifting men’s health: dealing with the spirit of our time. J Epidemiol Community Health 2020; 0:1–5. Doi: 10.1136/jech-2019-213165.
57. Chu T. Gender Differences in Pharmacokinetics. US Pharm. 2014; 39(9):40-43.
58. Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin
Pharmacokinet., 2012 September; 48(3):143-157. Doi: 10.2165/00003088-200948030-00001.
59. Rajpura JR, Nayak R. Role of illness perceptions and medication beliefs on medication compliance of elderly hypertensive cohorts. J Pharm Pract., 2014; Feb; 27(1):19–24. doi:10.1177/0897190013493806
60. Vaidya V, Partha G, Karmakar M. Gender differences in utilization of preventive care services in the United States. J Women’s Health. 2012; 21(2):140–145. Doi: 10.1089/jwh.
61. Emilsson M, et al. The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Prim Care Respir J, 2011 Jun; 20(2):141-7. doi: 10.4104/ pcrj. 2011.00005.
62. Holt E, et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults (CoSMO). J Am Geriatr Soc. 2013 Apr; 61(4): 558–564. doi:10.1111/jgs.12171.
63. Segarra I, Modamio P, Fernández C, Marino EL. Sex-divergent clinical outcomes and precision medicine: an important new role for institutional review boards and research ethics committees. Front Pharmacol. 2017 July 21; 8:488. doi:10.3389/Fphar.
64. Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Women’s Health. 2014 Feb;23(2): 112-119.doi:10.1089/jwh.
65. Mayo-Gamble TL, Mouton C. Examining the association between health literacy and
medication adherence among older adults. Health Communication.2018;33 (9):1124-1130.
66. Jin H, Kim Y, Rhie SJ. Factors affecting medication adherence in elderly people. Patient
Preference and Adherence. 2016 Oct 19; 10:2117-2125. doi: 10.2147/PPA.S118121.
67. Wang W, Lau Y, Loo A, Chow A; Thompson DR. Medication adherence and its associated factors among Chinese community-dwelling older adults with hypertension. Heart & Lung. Jul-Aug 2014;43(4):278-83. DOI: 10.1016/j.hrtlng.
68. Vélez-Vélez E, Bosch RJ. Illness perception, coping and adherence to treatment among patients with chronic kidney disease. J Adv Nurs. 2016;72(4):849–863. doi: 10.1111/jan.
69. Woith WM, Rappleyea ML. Emotional representation of tuberculosis with stigma, treatment delay, and medication adherence in Russia. J Health Psychol. 2016;21(5):770–780. Doi:10.1177/1359105315569620.
70. McClelland JF, Bodle L, Little JA. Investigation of medication adherence and reasons for
poor adherence in patients on long-term glaucoma treatment regimes. Patient Prefer
Adherence. 2019 Aug 12; 13:431-439. doi: 10.2147/PPA.S176412.
71. McMonnies CW. Glaucoma history and risk factors. J Optom., 2017 April-June; Vol. 10. Issue 2: pages 71-78. DOI: 10.1016/j.optom.
72. Sleath B, et al., The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011 Dec;118(12):2398-402.
doi: 10.1016/j.ophtha.
73. Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J., 2018; 22:18-033
doi: 10.7812/TPP/18-033.
74. Zaugg V; Korb-Savoldelli V; Durieux P; Sabatier B. Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication. Cochrane Database Syst Rev. 2018 Jan; (1): CD012042. doi: 10.1002/14651858.CD012042. pub2
75. Sabate E. Adherence to long-term therapies: evidence for action. World Health Organization (WHO). http://www.who.int/ chp/knowledge/publications/adherence report/en/. Accessed 28 June 2016.
76. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2012; 9:11–23.
77. Godman B, et al. Multiple policies to enhance prescribing efficiency for established medicines
in Europe with a particular focus on demand-side measures: findings and future implications.
Frontiers in Pharmacology, 2014; 5:106.
78. Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: making it safe and sound. The Kings Fund. 2013. http://www. kingsfund.org.uk/publications. Accessed 20 Feb 2016.
79. Ahrari S, Mohammadpour A, Amouzeshi, Z , Agha-Yousefi A. The Relationship between
Cognitive Appraisal and Adherence to Medical Regimens in Type 2 Diabetic Patients. J Caring Sci. 2014 Dec; 3(4): 277–285. doi: 10.5681/jcs.
80. Nieuwlaat R, et al. Interventions for enhancing medication adherence. Cochrane Database
Syst Rev. 2014 Nov 20;(11):CD000011. doi: 10. 1002 /14651858.CD000011.pub4.
81. Carpenter D, et al., Communication Predicts Medication Self-Efficacy in Glaucoma Patients. Optometry and Vision Science. July 2016, 93(7):731-737, doi:10.1097/OPX. 000000000000 0856.
82. Slota C, et al., Glaucoma patient expression of medication problems and non-adherence. Optom Vis Sci. 2015 May; 92(5): 537–543.doi: 10.1097/OPX.0000000000000574.
83. Sleath B. et al., Determinants of self-reported barriers to glaucoma medicine administration and adherence: A Multisite Study. Ann Pharmacother. 2014 Jul;48(7):856-862. doi: 10.1177/ 1060028014529413.
84. Carpenter DM, et al., The effect of eye drops technique education in patients with glaucoma.
Health Commun. 2016 Aug;31(8):1036-42. doi: 10.1080/10410236.2015.1020263.
85. Michie S, Atkins L, West R. The behaviour change wheel: a guide to designing interventions. 2015; London: Silverback Publishing
86. Lampert A, Bruckner T, Haefeli WE, Seidling HM. Improving eye-drop administration
skills of patients – A multicenter parallel-group cluster-randomized controlled trial. PLoS One, 2019; 14(2): e0212007. doi: 10.1371/journal.pone.0212007
87. Morgan, EE; Woods SP; Iudicello JE; Grant I; Villalobos J. Poor Self-efficacy for Healthcare Provider Interactions Among Individuals with HIV-Associated Neurocognitive Disorders. Journal of Clinical Psychology in Medical Settings, 2019, volume 26, pages13–24.
88. Gross IM, Hosek S, Richards MH, Fernandez MI. Predictors and profiles of antiretroviral
therapy adherence among African American adolescents and young adult males living with HIV. AIDS Patient Care STDS. 2016 Jul;30(7):324–38. doi: 10.1089/apc.
89. Richard L, Street, Jr. How clinician–patient communication contributes to health Improvement: Modeling pathways from talk to outcome. Patient Education and Counseling, September 2013;Volume 92, Issue 3, Pages 286-291.
90. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the
in the United States, 2010-2015-HIV Surveillance Supplemental Report. Mar,2018-07-31.
report-vol- 23-1.
91. Kelly M.; McCarthy S; Sahm LJ. Knowledge, attitudes and beliefs of patients and careers
regarding medication adherence: a review of qualitative literature. European Journal of Clinical Pharmacology. 2014, volume 70, pages1423–1431.
•
2. Tham Y, Li X, Wong TY, Quigley HA, Aung T, Cheng C. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology, 2015 July; Volume 122, Issue 7, Pages e40-e41.
3. World Health Organization. Situation Analysis of VISION 2020 in the WHO South-East Asia Region. 2012.
4. International Agency for the Prevention of Blindness (IAPB): Annual Report 2019.
https://www.iapb.org/wp-content/uploads/2019_IAPB_Annual_Report.pdf.
5. Abu Hussein NB, Eissa IM, Abdel-Kader AA. Analysis of Factors Affecting Patients’ Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model. J Ophthalmol., 2015. https://www.ncbi.nlm.nih.gov/pubmed/26167292.
6. Amin AM, Kamel AIM, El-Ashkar MGA. Corneal Topographic changes after sub scleral trabeculectomy. AIMJ 2020 February. doi:10.21608.
7. Khalaf FR, Qayed M, Fahmy HD, Wasfi EI, Mohamed AG. Employees Knowledge about
Glaucoma at Assiut University Employees. Assiut Scientific Nursing Journal. 2015 June; 3(5):11-17.
8. Smaje A, Clark MW, Raj R, Orlu M, Davis D, Rawle M. Factors associated with medication adherence in older patients: A systematic review. Aging Med (Milton). 2018 Dec; 1(3): 254–266.
9. Facts About Glaucoma". National Eye Institute. Archived from the original on 2016 March 28.
10. Eldaly MA, Salama MM, Abu Eleinen KG, Ghalwash D, Youssef M, El-Shiaty AF. Blindness and Visual Impairment among Egyptian Glaucoma Patients. Journal of Ophthalmology, 2014; Article ID 437548.
11. Vos T. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study. Lancet 2016; 388: 1545–602.
12. Zhong H, et al. The Prevalence of Glaucoma in Adult Rural Chinese Populations of the Bai
Nationality in Dali: The Yunnan Minority Eye Study. Investigative Ophthalmology & Visual
Science, 2012 May; Vol.53, 3221-3225. doi: https://doi.org/10.1167/iovs.11-9306.
13. National Eye Institute. Glaucoma: The “silent thief begins to tell its secrets”. 2015 January. Archived from the original on 23 July,2014.
14. Mantravadi AV, Vadhar N. Glaucoma - Primary Care: Clinics in Office Practice, 2015 Sept; Volume 41, Issue 3,P437-449 DOI: https://doi.org/10.1016/j.pop.
15. Vin A, Schneider S, Muir KW, Rosdahl JA. Health coaching for glaucoma care: a pilot study
using mixed methods. Clinical ophthalmology (Auckland, N.Z.). 2015 Oct 22; 9:1931-43.
16. Sleath B, et al. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology, 2015 Apr 1; 122(4):748-54.
17. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163–96.
18. Mahmoodi H, Jalalizad NF, Shaghaghi A, Shooshtari S, Jafarabadi MA, Allahverdipour H. Gender Based Cognitive Determinants Of Medication Adherence In Older Adults With Chronic Conditions. Patient Preference and Adherence, 2019 October 15; Volume:13 Pages 1733—1744. DOI https://doi.org/10.2147/PPA.S219193.
19. Lee S, Jiang L, Dowdy D, Hong YA, Ory MG. Attitudes, Beliefs, and Cost-Related Medication Nonadherence Among Adults Aged 65 or Older with Chronic Diseases. Prev Chronic Dis 2018; 15:180190. DOI: http://dx.doi.org/10.5888/pcd15.180190external icon.
20. Patton DE, Cadogan CA, Ryan C, Francis JJ, Gormley GJ, Passmore P, Kerse N, Hughes CM. Improving adherence to multiple medications in older people in primary care: Selecting intervention components to address patient-reported barriers and facilitators. Health Expect. 2018 Feb; 21(1):138-148. doi: 10.1111/hex.12595.
21. Patton DE, Hughes CM, Cadogan CA, Ryan CA. Theory-Based Interventions to Improve Medication Adherence in Older Adults Prescribed Polypharmacy: A Systematic Review. Drugs and Aging, 2017; 34:97–113 DOI 10.1007/s40266-016-0426-6.
22. Sleath B, et al., Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations. Eye (2010) 24, 624–631.
23. Kashiwagi K, Furuya T. Persistence with topical glaucoma therapy among newly diagnosed Japanese patients. Japanese Journal of Ophthalmology, 2014: volume 58, pages 68–74.
24. Campbell J, Schwartz G, LaBounty B, Kowalski J, Patel V. Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions. 2014 May; Volume 4:8 Pages 927-935.
25. McVeigh K, Vakros G. The eye drop chart: A pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clinical ophthalmology, 2015 May. DOI: 10.2147/OPTH.S82909.
26. Verloo H, Chiolero A, Kiszio B, Kampel T, Santschi V. Nurse interventions to improve medication adherence among discharged older adults: a systematic review. Age & Ageing, 2017 Sept; 46(5):747-754. doi: 10.1093/ageing/afx076.
27. Iuga AO and McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014 Feb 20; 7:35-44. doi: 10.2147/RMHP.S19801.
28. Al-Lawati S. Report on Patient Non-adherence in Ireland. Dublin: Pfizer Healthcare Ireland, Irish Pharmacy Union, Irish patients’ Association; 2014 March; Pp 52.
29. Vrijens B, et al., A new taxonomy for describing and defining adherence to medications. Br J
Clin Pharmacol. 2012 May; 73(5):691-705. doi: 10.1111/j.1365-2125.2012.04167
30. Lopez-Garrido G. Self-efficacy. Simply Psychology, Aug 09, 2020, https://www .simply psychology.org/self-efficacy.html
31. Conner MT. Cognitive Determinants of Health Behavior. Handbook of Behavioral Medicine.
2010 August; pp 19-30. DOI: 10.1007/978-0-387-09488-5_2
32. Bandura A. Social cognitive theory: an agentic perspective. Annu Rev Psychol., 2001; 52:1-26.
doi: 10.1146/annurev.psych.52.1.1.
33. Redmond BF. Self- efficacy Theory: Do I Think that I can succeed in my work? Work attitudes & motivations. (2010), The Pennsylvania state University; World Campus
34. Bandura A. Self-efficacy: toward a unifying theory of behavioral change Psychol Rev. 1977
Mar; 84(2): 191-215. doi: 10.1037//0033-295x.84.2.191.
35. Schunk DH. "Goal Setting and Self-Efficacy During Self-Regulated Learning" . Educational Psychologist, 2010 Jun 08; Pages 71-86.
36. Conner M, & Norman P. Predicting health behavior (2nd ed.). Buckingham, England: Open University Press. 2005.
37. Porter LW, Bigley GA, Steers RM. Motivation and Work Behavior. McGraw-Hill Irwin, Digital format Book, 2011 April; (7th ed.), p. 131–132.
38. Bandura A. Social Learning Theory, Alexandria, VA: Prentice Hall, 1977, pp. 247, ISBN 978-0- 13-816744-8.
39. Atkins L, et al., A guide to using the theoretical domains framework of behavior change to investigate implementation problems. Implement Sci.,2017 Jun 21;12(1):77. DOI: 10.1186/s
13012-017-0605-9.
40. Michie S, et al., The behavior changes technique taxonomy (v1) of 93 hierarchically clustered techniques: Building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013; 46:81‐95.
41. Hughes CM; Cadogan CA; Patton D; Ryan CA. Pharmaceutical strategies towards optimizing polypharmacy in older people. Int J Pharm. 2016; Volume 512, Issue 2:360‐365.
42. Patton DE, Ryan C, Hughes CM. Development of a complex community pharmacy intervention package using theory-based behaviour change techniques to improve older adult’s medication adherence, BMC Health Services Research, 2020. 10.1186/s12913-020-05282-7.
43. Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current Situation of Medication Adherence in Hypertension. Front. Pharmacol.,2017, March. https://doi.org/10.3389/fphar.2017.00100.
44. Kardas P, Lewek P, Matyjaszczyk M . Determinants of patient adherence: a review of
systematic reviews. Front Pharmacol. 2013 Jul 25; 4: 91. Doi:10. 3389/ fphar.2013.00091.
45. Navarra AMD, Gwadz MV, Bakken S, Whittemore R, Cleland CM, Melkus GD. Adherence
Connection for Counseling, Education, and Support: Research Protocol for a Proof-of-
Concept Study. JMIR Res Protoc. 2019 Mar; 8(3): e12543. doi: 10.2196/12543.
46. Lubloy A. Factors affecting the uptake of new medicines: a systematic literature review.
BMC Health Services Research. 2014; 14:469
47. Unni EJ , Olson JL , Farris KB. Revision and validation of Medication Adherence Reasons
Scale (MAR-Scale). Journal Current Medical Research and Opinion . 2014, Volume 30, Issue 2.
48. Herndon LW, Brunner TM, Rollins JN. The Glaucoma Research Foundation Patient
Survey: patient understanding of glaucoma and its treatment. Am J Ophthalmol., 2006; 141:
22–28.
49. Ma HJ, Yen M, Chen CH, Liou D (2015). Determinants of the medication adherence behavior
among elderly patients with coronary heart diseases. Journal of Nursing Education and
Practice, 2015, Vol. 5, No.7
50. Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, Taddei G C, Casati M, Franchi C, Djade C D, Nobili A. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014 Apr;31(4):283- 9. doi: 10.1007/ s40266-014-0163-7.
51. Pagès-Puigdemont N, Tuneu L, Masip M, Valls P, Puig T, Mangues MA. Determinants of medication adherence among chronic patients from an urban area: a cross-sectional study.
European Journal of Public Health, Jun 2019; Volume 29, Issue 3, Pages 419–424.
52. Kharameh ZT, Khoshravesh S, Nouri R, Abdolmalaki M, Bakhshi M. Determinants of
Medication Adherence Among Iranian Elderly Patients with Chronic Diseases. Jundishapur
Journal of Chronic Disease Care in Press (In Press). 2018. DOI: 10.5812/jjcdc.68310.
53. Sirey JA, Weinberger MI, Greenfield A, Bruce ML. Medication beliefs and self-reported
adherence among community-dwelling older adults. Clinical Therapeutics, 2013 26 Jan,
35(2):153-160. DOI: 10.1016/j.clinthera.2013.01.001.
54. Al-Mansouri FA, Kanaan A, Gamra H, Khandekar R, Hashim SP, Al Qahtani O, Ahmed MF. Prevalence and Determinants of Glaucoma in Citizens of Qatar Aged 40 Years or Older:
A Community-Based SurveyMiddle East Afr J Ophthalmol. 2011 Apr-Jun; 18(2): 141-149.doi:10.4103/0974-9233.80703.
55. Zucker I & Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug
reactions in women. Biology of Sex Differences volume 11, Article number: 32 (2020).
56. Marcos-Marcos J; Gasch-Gallén A; Mateos JT; Álvarez-Dardet C. Advancing gender
equ(al)ity, lifting men’s health: dealing with the spirit of our time. J Epidemiol Community Health 2020; 0:1–5. Doi: 10.1136/jech-2019-213165.
57. Chu T. Gender Differences in Pharmacokinetics. US Pharm. 2014; 39(9):40-43.
58. Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin
Pharmacokinet., 2012 September; 48(3):143-157. Doi: 10.2165/00003088-200948030-00001.
59. Rajpura JR, Nayak R. Role of illness perceptions and medication beliefs on medication compliance of elderly hypertensive cohorts. J Pharm Pract., 2014; Feb; 27(1):19–24. doi:10.1177/0897190013493806
60. Vaidya V, Partha G, Karmakar M. Gender differences in utilization of preventive care services in the United States. J Women’s Health. 2012; 21(2):140–145. Doi: 10.1089/jwh.
61. Emilsson M, et al. The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Prim Care Respir J, 2011 Jun; 20(2):141-7. doi: 10.4104/ pcrj. 2011.00005.
62. Holt E, et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults (CoSMO). J Am Geriatr Soc. 2013 Apr; 61(4): 558–564. doi:10.1111/jgs.12171.
63. Segarra I, Modamio P, Fernández C, Marino EL. Sex-divergent clinical outcomes and precision medicine: an important new role for institutional review boards and research ethics committees. Front Pharmacol. 2017 July 21; 8:488. doi:10.3389/Fphar.
64. Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Women’s Health. 2014 Feb;23(2): 112-119.doi:10.1089/jwh.
65. Mayo-Gamble TL, Mouton C. Examining the association between health literacy and
medication adherence among older adults. Health Communication.2018;33 (9):1124-1130.
66. Jin H, Kim Y, Rhie SJ. Factors affecting medication adherence in elderly people. Patient
Preference and Adherence. 2016 Oct 19; 10:2117-2125. doi: 10.2147/PPA.S118121.
67. Wang W, Lau Y, Loo A, Chow A; Thompson DR. Medication adherence and its associated factors among Chinese community-dwelling older adults with hypertension. Heart & Lung. Jul-Aug 2014;43(4):278-83. DOI: 10.1016/j.hrtlng.
68. Vélez-Vélez E, Bosch RJ. Illness perception, coping and adherence to treatment among patients with chronic kidney disease. J Adv Nurs. 2016;72(4):849–863. doi: 10.1111/jan.
69. Woith WM, Rappleyea ML. Emotional representation of tuberculosis with stigma, treatment delay, and medication adherence in Russia. J Health Psychol. 2016;21(5):770–780. Doi:10.1177/1359105315569620.
70. McClelland JF, Bodle L, Little JA. Investigation of medication adherence and reasons for
poor adherence in patients on long-term glaucoma treatment regimes. Patient Prefer
Adherence. 2019 Aug 12; 13:431-439. doi: 10.2147/PPA.S176412.
71. McMonnies CW. Glaucoma history and risk factors. J Optom., 2017 April-June; Vol. 10. Issue 2: pages 71-78. DOI: 10.1016/j.optom.
72. Sleath B, et al., The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011 Dec;118(12):2398-402.
doi: 10.1016/j.ophtha.
73. Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J., 2018; 22:18-033
doi: 10.7812/TPP/18-033.
74. Zaugg V; Korb-Savoldelli V; Durieux P; Sabatier B. Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication. Cochrane Database Syst Rev. 2018 Jan; (1): CD012042. doi: 10.1002/14651858.CD012042. pub2
75. Sabate E. Adherence to long-term therapies: evidence for action. World Health Organization (WHO). http://www.who.int/ chp/knowledge/publications/adherence report/en/. Accessed 28 June 2016.
76. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2012; 9:11–23.
77. Godman B, et al. Multiple policies to enhance prescribing efficiency for established medicines
in Europe with a particular focus on demand-side measures: findings and future implications.
Frontiers in Pharmacology, 2014; 5:106.
78. Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: making it safe and sound. The Kings Fund. 2013. http://www. kingsfund.org.uk/publications. Accessed 20 Feb 2016.
79. Ahrari S, Mohammadpour A, Amouzeshi, Z , Agha-Yousefi A. The Relationship between
Cognitive Appraisal and Adherence to Medical Regimens in Type 2 Diabetic Patients. J Caring Sci. 2014 Dec; 3(4): 277–285. doi: 10.5681/jcs.
80. Nieuwlaat R, et al. Interventions for enhancing medication adherence. Cochrane Database
Syst Rev. 2014 Nov 20;(11):CD000011. doi: 10. 1002 /14651858.CD000011.pub4.
81. Carpenter D, et al., Communication Predicts Medication Self-Efficacy in Glaucoma Patients. Optometry and Vision Science. July 2016, 93(7):731-737, doi:10.1097/OPX. 000000000000 0856.
82. Slota C, et al., Glaucoma patient expression of medication problems and non-adherence. Optom Vis Sci. 2015 May; 92(5): 537–543.doi: 10.1097/OPX.0000000000000574.
83. Sleath B. et al., Determinants of self-reported barriers to glaucoma medicine administration and adherence: A Multisite Study. Ann Pharmacother. 2014 Jul;48(7):856-862. doi: 10.1177/ 1060028014529413.
84. Carpenter DM, et al., The effect of eye drops technique education in patients with glaucoma.
Health Commun. 2016 Aug;31(8):1036-42. doi: 10.1080/10410236.2015.1020263.
85. Michie S, Atkins L, West R. The behaviour change wheel: a guide to designing interventions. 2015; London: Silverback Publishing
86. Lampert A, Bruckner T, Haefeli WE, Seidling HM. Improving eye-drop administration
skills of patients – A multicenter parallel-group cluster-randomized controlled trial. PLoS One, 2019; 14(2): e0212007. doi: 10.1371/journal.pone.0212007
87. Morgan, EE; Woods SP; Iudicello JE; Grant I; Villalobos J. Poor Self-efficacy for Healthcare Provider Interactions Among Individuals with HIV-Associated Neurocognitive Disorders. Journal of Clinical Psychology in Medical Settings, 2019, volume 26, pages13–24.
88. Gross IM, Hosek S, Richards MH, Fernandez MI. Predictors and profiles of antiretroviral
therapy adherence among African American adolescents and young adult males living with HIV. AIDS Patient Care STDS. 2016 Jul;30(7):324–38. doi: 10.1089/apc.
89. Richard L, Street, Jr. How clinician–patient communication contributes to health Improvement: Modeling pathways from talk to outcome. Patient Education and Counseling, September 2013;Volume 92, Issue 3, Pages 286-291.
90. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the
in the United States, 2010-2015-HIV Surveillance Supplemental Report. Mar,2018-07-31.
report-vol- 23-1.
91. Kelly M.; McCarthy S; Sahm LJ. Knowledge, attitudes and beliefs of patients and careers
regarding medication adherence: a review of qualitative literature. European Journal of Clinical Pharmacology. 2014, volume 70, pages1423–1431.
Downloads
Published
2020-10-29
How to Cite
Abou-El-Soud, F. A., & Mohamed, H. S. (2020). IMPACT OF SELF-EFFICACY THEORY ON IMPROVING ADHERENCE OF OLDER ADULTS PATIENTS WITH GLAUCOMA’S MEDICATION. Journal of Health, Medicine and Nursing, 5(4), 44 – 70. https://doi.org/10.47604/jhmn.1160
Issue
Section
Articles
License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
